Collaborative Multidisciplinary Workshop Report: Progress toward aChlamydia pneumoniaeVaccine

Abstract

Andrew D. Murdin,',a Bruce Gellin,4,a Robert C. Brunham,2 Lee Ann Campbell,s Gunna Christiansen,3 Carolyn D. Deal,6 Hal B. Jenson,7 Benjamin Metcalf,8 Banu Sankaran,' Richard S. Stephens,o and Cathy Wilfert 'Molecular Biology, Aventis Pasteur, Toronto, and 2University of British Columbia Centre for Disease Control, Faculty of Medicine, University of British Columbia, Vancouver, Canada; 3Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus, Denmark, 4Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 5Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington; 6Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland; 7Department of Pediatrics and Microbiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; 'Molecular Biology and Genetics and 9Protein Chemistry, Wyeth Lederle Vaccines, West Henrietta, New York; Division of Infectious Diseases, School of Public Health, University of California at Berkeley, Berkeley, California; Departments of Pediatrics and Microbiology, Duke University Medical Center, Chapel Hill, North Carolina